Interactions of HIV-1 Capsid with Host Factors and Their Implications for Developing Novel Therapeutics.

Article Details

Citation

Copy to clipboard

Zhuang S, Torbett BE

Interactions of HIV-1 Capsid with Host Factors and Their Implications for Developing Novel Therapeutics.

Viruses. 2021 Mar 5;13(3). pii: v13030417. doi: 10.3390/v13030417.

PubMed ID

33807824 [ View in PubMed

]

Abstract

The Human Immunodeficiency Virus type 1 (HIV-1) virion contains a conical shell, termed capsid, encasing the viral RNA genome. After cellular entry of the virion, the capsid is released and ensures the protection and delivery of the HIV-1 genome to the host nucleus for integration. The capsid relies on many virus-host factor interactions which are regulated spatiotemporally throughout the course of infection. In this paper, we will review the current understanding of the highly dynamic HIV-1 capsid-host interplay during the early stages of viral replication, namely intracellular capsid trafficking after viral fusion, nuclear import, uncoating, and integration of the viral genome into host chromatin. Conventional anti-retroviral therapies primarily target HIV-1 enzymes. Insights of capsid structure have resulted in a first-in-class, long-acting capsid-targeting inhibitor, GS-6207 (Lenacapavir). This inhibitor binds at the interface between capsid protein subunits, a site known to bind host factors, interferes with capsid nuclear import, HIV particle assembly, and ordered assembly. Our review will highlight capsid structure, the host factors that interact with capsid, and high-throughput screening techniques, specifically genomic and proteomic approaches, that have been and can be used to identify host factors that interact with capsid. Better structural and mechanistic insights into the capsid-host factor interactions will significantly inform the understanding of HIV-1 pathogenesis and the development of capsid-centric antiretroviral therapeutics.

DrugBank Data that Cites this Article

Drugs

Lenacapavir

Drug Targets

Drug	Target	Kind	Organism	Pharmacological Action	Actions
Lenacapavir	Gag-Pol polyprotein	Protein		Yes	Inhibitor	Details